Dr. Karl Vance Sitz, MD

  • Little Rock, AR
  • Allergy and immunology (internal medicine) physician
NPI1518959691
Medicare services, 2024
35
Medicare patients, 2024
33
Part D claims, 2024
141
Publications
3
Clinical trials
3
Practice address
18 Corporate Hill Dr, Little Rock, AR 72205
Practice phone
Call (501) 224-1156
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Little Rock Allergy & Asthma Clinic PA

Little Rock, Arkansas

Find Dr. Sitz's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Karl Vance Sitz is an allergy and immunology (internal medicine) physician in Little Rock, Arkansas

Dr. Sitz practices at Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas.

Dr. Sitz's NPI, 1518959691, was assigned on August 16, 2005. Dr. Sitz holds Arkansas license C7148.

NPI and contact details
NPI enumeration date
August 16, 2005
NPI status
Active
Practice phone
(501) 224-1156
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Dr. Karl Vance Sitz practices at Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas

Dr. Sitz's primary practice is Little Rock Allergy & Asthma Clinic PA, at 18 Corporate Hill Dr, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 224-1156.

  • Little Rock Allergy & Asthma Clinic PA
    18 Corporate Hill Dr, Little Rock, AR 72205 · Pulaski CountyPhone(501) 224-1156

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Karl Vance Sitz is affiliated with 1 site of care

Dr. Sitz's primary practice is Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas.

Little Rock Allergy & Asthma Clinic PALittle Rock, ArkansasPrimary

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Karl Vance Sitz's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sitz practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Little Rock Allergy & Asthma Clinic PAAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Sitz practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Karl Vance Sitz is one of 5 allergys and immunology (internal medicine) physicians in Arkansas

Allergy and immunology is Dr. Sitz's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dr. Sitz is licensed in Arkansas.

Specialties and state licenses

  • Allergy and immunology (internal medicine), ArkansasPrimaryLicense C7148 · taxonomy 207RA0201X

Allergys and immunology (internal medicine) physicians near Dr. Sitz

Counts of allergys and immunology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.

5allergys and immunology (internal medicine) physicians in Arkansas
5allergys and immunology (internal medicine) physicians in Little Rock

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Karl Vance Sitz billed Medicare for 35 services in 2024

CMS data shows 35 Medicare services from Dr. Sitz across 1 procedure code in 2024, for 33 Medicare patients. Medicare paid $221 for them. Every service was in an office.

Medicare services, 202435
Medicare patients33
Paid by Medicare$221
Procedure codes1

Dr. Sitz's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Tests and treatments
2023: 5,0612024: 3599%
Office and hospital visits
2023: 2452024: 0100%

Dr. Sitz's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sitz

Need commercial claims for Dr. Sitz?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sitz and other allergys and immunology (internal medicine) physicians in Arkansas.

Book a meeting

Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data

Dr. Karl Vance Sitz treated 33 Medicare patients in 2024, average age 71

CMS counts 33 Medicare patients who saw Dr. Sitz in 2024. The largest group is 65 to 74, with 19 patients. 70% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.90, where 1.00 is the Medicare average.

Medicare patients, 202433
Average age71
Average risk score0.90

Dr. Sitz's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Sitz's Medicare patients by sex, 2024

  • Women2164%
  • Men1236%

Chronic conditions among Dr. Sitz's Medicare patients, 2024

  1. High cholesterol70%
  2. High blood pressure67%
  3. Arthritis58%
  4. Diabetes42%
  5. Asthma39%

Share of Medicare patients with each condition. A patient can have several.

Source: Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Karl Vance Sitz wrote 141 Medicare Part D claims in 2024

In 2024, Dr. Sitz wrote 141 Medicare Part D claims for 58 patients. 69% of them were for generic drugs. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $10,827 in total drug cost. In 2023, CMS named 564 claims across 15 drugs.

Part D claims, 2024141
Drugs named by CMS4
Total drug cost$10,827
Part D patients58

Dr. Sitz's Part D claims by kind of drug, 2024

  • Generic97 claims69%
  • Brand-name44 claims31%

Dr. Sitz's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5642024: 7287%

Drugs named by CMS: 4 in 2024, 15 in 2023.

See all prescribing by Dr. Sitz

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Karl Vance Sitz scored 76 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Sitz for performance year 2024, reported as part of a group.

Dr. Sitz's MIPS scores, performance year 2024

  • 76of 100Final score
  • 50.7of 100Quality
  • 40of 100Improvement Activities
  • 84of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find allergys and immunology (internal medicine) physicians like Dr. Sitz by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Karl Vance Sitz has 3 publications on record

Dmand AI links 3 papers to Dr. Sitz, published from 2020 to 2022. Dr. Sitz's most frequent co-authors are Jonathan A. Bernstein, MD, Aleena Banerji, MD and Paula J. Busse, MD.

Papers3
Years published2020 to 2022

Dr. Sitz's papers by year, 2020 to 2022

Dr. Sitz's most frequent co-authors

Recent publications by Dr. Sitz

See all 3 publications and co-authors

See who Dr. Sitz researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sitz works with, so you can find a warm path to the right allergys and immunology (internal medicine) physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Karl Vance Sitz has worked on 3 clinical trials

Dmand AI links Dr. Sitz to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Respiratory Hypersensitivity and Hereditary Complement Deficiency Diseases. GlaxoSmithKline sponsors the most, 2. Open Payments lists research payments to Dr. Sitz that name 1 trial.

Clinical trials with Dr. Sitz by phase

  1. NonePhase 1: no trials
  2. NonePhase 2: no trials
  3. 1Phase 3: 1 trial
  4. 1Phase 4: 1 trial

Conditions in Dr. Sitz's trials

  • Asthma
  • Respiratory Hypersensitivity
  • Hereditary Complement Deficiency Diseases
  • Angioedemas, Hereditary

Investigators on the most trials with Dr. Sitz

Recent clinical trials with Dr. Sitz

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Karl Vance Sitz received $25,495 in industry payments from 2016 to 2025

CMS Open Payments shows 478 general payments to Dr. Sitz from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 39% of the total. CSL Behring paid the most, $10,697. It also lists 36 research payments totaling $87,398 from 2016 to 2024, naming 1 clinical trial.

General payments to Dr. Sitz by program year, 2016 to 2025

General payments to Dr. Sitz by kind, 2016 to 2025

$25.5Kin total
  • Speaker and faculty fees$9,89739%
  • Food and beverage$8,98835%
  • Travel and lodging$4,39817%
  • Honoraria$2,1008%
  • Other$1130%

Companies that paid Dr. Sitz the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sitz

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Karl Vance Sitz's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
Medicare patients and the all-payer patient panelMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesClinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Karl Vance Sitz

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Karl Vance Sitz's NPI number?

Dr. Karl Vance Sitz's NPI number is 1518959691. It was assigned on August 16, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Karl Vance Sitz?

Dr. Karl Vance Sitz is an allergy and immunology (internal medicine) physician in Little Rock, Arkansas. The primary specialty in the NPI Registry is Allergy & Immunology (Internal Medicine) Physician (taxonomy code 207RA0201X).

Where does Dr. Karl Vance Sitz practice?

Dr. Sitz practices at 18 Corporate Hill Dr, Little Rock, AR 72205. Dr. Sitz's primary practice is Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas.

What is Dr. Karl Vance Sitz's office phone number?

The practice phone on file for Dr. Sitz is (501) 224-1156.

What is Dr. Karl Vance Sitz's medical license number?

Dr. Sitz holds Arkansas license C7148.

Does Dr. Karl Vance Sitz accept Medicare?

Yes. CMS data shows Dr. Sitz billed Medicare for 35 services in 2024.

What is Dr. Karl Vance Sitz's MIPS score?

Dr. Sitz's MIPS final score for performance year 2024 is 76 out of 100, reported as part of a group.

How many Medicare patients does Dr. Karl Vance Sitz see?

CMS counts 33 Medicare patients who saw Dr. Sitz in 2024, with an average age of 71.

What services does Dr. Karl Vance Sitz bill to Medicare?

In 2024, Dr. Sitz's most billed Medicare services were allergy test or treatment (95115).

What drugs does Dr. Karl Vance Sitz prescribe most?

In 2024 Medicare Part D data, Dr. Sitz's most prescribed drugs by claims were Azelastine HCl, Ipratropium Bromide and Fluticasone Propionate.

Show 4 more questionsShow fewer questions

Has Dr. Karl Vance Sitz received payments from drug or device companies?

CMS Open Payments shows $25,495 in general payments to Dr. Sitz from 34 companies from 2016 to 2025. The largest total came from CSL Behring.

How long has Dr. Karl Vance Sitz been practicing?

Dr. Sitz's NPI was assigned in 2005.

Does Dr. Karl Vance Sitz do research?

Dmand AI links 3 publications to Dr. Sitz, published from 2020 to 2022. Dr. Sitz has worked on 3 clinical trials.

Who does Dr. Karl Vance Sitz publish with?

Dr. Sitz's most frequent co-authors are Jonathan A. Bernstein, MD (2 shared papers), Aleena Banerji, MD (1 shared paper) and Paula J. Busse, MD (1 shared paper).

Selling to allergy and immunology practices?

See allergys and immunology (internal medicine) physicians in Arkansas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)